Silver Book Fact

Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs therapies; looking for the cause of the disease and continuing to search for environmental and genetic factors; and working to develop new protective drugs that can delay, reverse, or even prevent the disease.

National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH. Parkinson’s Disease Information Page; 2007. http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm

Reference

Title
Parkinson’s Disease Information Page
Publication Date
2007
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Delaying the onset of Alzheimer’s by only 5 years could reduce the number of people with Alzheimer’s by almost 50% after 50 years.  
  • The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.  
  • It is imperative to weigh costs of implementing new technologies for predicting onset of Alzheimer’s disease through biomarkers and delaying onset earlier against the potential benefits of improving health. Overall…  
  • Around 75 – 100 experimental therapies that are aimed at slowing or stopping the progression of Alzheimer’s disease are currently in clinical trials.  
  • Studies have shown that active medical management of Alzheimer’s disease can significantly improve quality-of-life for the individual through all stages of the disease.